The Yale Echo Laboratory is comprised of 9 board-certified cardiologists and over 17 registered cardiac sonographers performing transthoracic, stress, and transesophageal echocardiography using state-of-the-art equipment capable of 2D and 3D imaging, intracavitary contrast, and strain imaging. The lab actively supports rapidly growing programs within the section, including percutaneous aortic valve insertions, atrial fibrillation ablation, and left ventricular assist devices. The lab has been digital for over a decade and has image management software that enables database search and off-line processing of 3D and strain images.
Under the leadership of Academic Director Dr. Joseph Akar, Associate Professor of Medicine and Clinical Director, Dr. Mark Marieb, Associate Professor of Medicine, the electrophysiology program provides a full spectrum of rhythm management services.These include a Complex Ablation Program (Dr. Akar, Director) focused on atrial fibrillation and ventricular tachycardia that offers epicardial ablation approaches, and a high volume Lead Management Program (Dr. Jude Clancy, Director) that provides laser-based device lead extraction, as well as a comprehensive menu of other EP services.The EP lab also provides national physician education courses on the use of intracardiac echocardiography (ICE). Current clinical trials in the EP laboratories include first-in-man clinical evaluation of 3D ICE, a registry for MRI safety with ICD patients, an NIH-sponsored study examining the effects of mental stress on arrhythmogenesis, the MADIT-CRT post-approval study, and studies examining the use of remote monitoring of ICD's, among others.
Directed by Daniel Dries, MD, , Associate Professor of Medicine in collaboration with Abeel Mangi, MD, Assistant Professor of Surgery, the Advanced Heart Failure program provides a comprehensive, multi-disciplinary approach to patients with advanced heart failure. This includes optimization of advanced heart failure medical management, use of cardiopulmonary exercise testing to determine prognosis, and evaluation for advanced therapies such as short-term and long-term mechanical support platforms and cardiac transplantation. The Center also offers a destination LVAD Program that provides long-term mechanical circulatory support to patients otherwise ineligible for heart transplant. Yale is the only center in New England participating in the ROADMAP Study that is examining the use of mechanical circulatory support earlier in the disease process in patients otherwise ineligible for heart transplant. The Syncardia Total Artificial Heart as a mechanical circulatory support platform is also available to appropriate individuals. In 2011 Yale performed 16 transplants and 19 LVAD implantations and our heart transplant survival and post LVAD rates are among the best in the region.
Inpatient cardiovascular services encompass CCU and the step down unit, the Goodyer service (general inpatient cardiology) and the consult service. The CCU/step-down service, directed by Joseph Brennan, MD, Associate Professor of Medicine, provides full time management for patients with acute coronary syndromes. The Goodyer service, directed by Lynda Rosenfeld, MD, Associate Professor of Medicine, is dedicated to inpatient management of patients with a wide spectrum of cardiovascular illnesses spectrum of cardiovascular illnesses and their safe transition to outpatient care while the consult service makes Yale cardiology expertise available to all physicians and patients in the Yale New Haven Hospital.